We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$9.86B
AUM Growth
-$168M
Cap. Flow
-$326M
Cap. Flow %
-3.31%
Top 10 Hldgs %
9.48%
Holding
825
New
63
Increased
274
Reduced
363
Closed
64

Top Buys

Rank Stock Value
1
JJSF icon
J&J Snack Foods
JJSF
+$29.7M
2
WDFC icon
WD-40
WDFC
+$28.7M
3
CBZ icon
CBIZ
CBZ
+$27.6M
4
EXPO icon
Exponent
EXPO
+$19.4M
5
ANDG
Andersen Group
ANDG
+$19.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.96%
2 Technology 18.79%
3 Financials 16.43%
4 Consumer Discretionary 12.93%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACA icon
1
Arcosa
ACA
$7.14B
$131M 1.33%
1,234,455
-32,636
-3% -$3.29M
KWR icon
2
Quaker Houghton
KWR
$2.92B
$104M 1.05%
755,740
+121,854
+19% +$16.5M
JBTM
3
JBT Marel
JBTM
$6.14B
$101M 1.02%
668,588
+28,335
+4% +$4M
ESAB icon
4
ESAB
ESAB
$4.91B
$100M 1.02%
898,009
+112,503
+14% +$12.9M
MKSI icon
5
MKS Inc
MKSI
$17.9B
$98.5M 1%
616,605
-210,522
-25% -$31.2M
AGO icon
6
Assured Guaranty
AGO
$3.35B
$88.4M 0.9%
983,385
-52,442
-5% -$4.52M
LCII icon
7
LCI Industries
LCII
$2.49B
$79.2M 0.8%
653,056
-18,948
-3% -$2.02M
CRUS icon
8
Cirrus Logic
CRUS
$5.51B
$79.2M 0.8%
668,334
-45,665
-6% -$5.62M
IGIC icon
9
International General Insurance
IGIC
$1.14B
$79.1M 0.8%
3,151,198
-22,428
-0.7% -$526K
SEIC icon
10
SEI Investments
SEIC
$13.4B
$74.3M 0.75%
906,339
+2,756
+0.3% +$227K
UFPI icon
11
UFP Industries
UFPI
$4.71B
$73.4M 0.74%
806,395
+38,021
+5% +$3.48M
ESE icon
12
ESCO Technologies
ESE
$7.29B
$70.9M 0.72%
362,706
-666
-0.2% -$140K
IESC icon
13
IES Holdings
IESC
$13.1B
$66.7M 0.68%
342,686
-10,170
-3% -$2.04M
NGVT icon
14
Ingevity
NGVT
$2.41B
$65.8M 0.67%
1,111,158
+79,059
+8% +$4.29M
FORM icon
15
FormFactor
FORM
$8.38B
$64.6M 0.65%
1,157,891
-310,842
-21% -$15.7M
VMI icon
16
Valmont Industries
VMI
$9.25B
$62.7M 0.64%
155,893
-15,610
-9% -$6.35M
DORM icon
17
Dorman Products
DORM
$3.82B
$61.5M 0.62%
498,959
+1,538
+0.3% +$208K
SII
18
Sprott
SII
$3.56B
$61.1M 0.62%
623,344
-40,770
-6% -$3.62M
RBC icon
19
RBC Bearings
RBC
$16.1B
$59.7M 0.61%
133,126
+807
+0.6% +$342K
ESI icon
20
Element Solutions
ESI
$8.89B
$58.9M 0.6%
2,358,076
-316,913
-12% -$8.23M
LFUS icon
21
Littelfuse
LFUS
$10.5B
$58.7M 0.6%
232,259
-9,876
-4% -$2.51M
KAI icon
22
Kadant
KAI
$3.58B
$58.4M 0.59%
204,937
+48,286
+31% +$13.7M
AAP icon
23
Advance Auto Parts
AAP
$2.64B
$58.1M 0.59%
1,478,633
+345,217
+30% +$17.3M
BRC icon
24
Brady Corp
BRC
$4.43B
$58M 0.59%
740,635
+66,387
+10% +$5.14M
FSV icon
25
FirstService
FSV
$6.17B
$58M 0.59%
372,861
+12,718
+4% +$2.07M

Similar funds

Royce & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Royce & Associates held 825 positions worth $9.86B, down 1.7% from $10B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2025, closing 64 positions and reducing 363 holdings. Its most notable exit was Charles River Laboratories, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in J&J Snack Foods worth $29.6M.

  • Royce & Associates's largest Q4 2025 buy was J&J Snack Foods: 327,501 shares worth $29.6M.
  • Royce & Associates added most to WD-40 in Q4 2025, an estimated $28.7M increase.
  • Royce & Associates's biggest Q4 2025 reduction was Haemonetics, cutting an estimated $42.3M.
  • Royce & Associates fully exited Charles River Laboratories in Q4 2025, selling an estimated $13.2M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $9.86B portfolio in Q4 2025.
  • Royce & Associates opened 63 new positions and closed 64 in Q4 2025.
  • Royce & Associates's portfolio value fell 1.7% quarter-over-quarter to $9.86B.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.